Covid 19 in Patients with Renal Diseases
Author(s): Ajinkya Kalbande* and Pramita Muntode
Abstract
Whole world has been frightened because of the rapid rise in the number of cases and deaths due to novel corona virus (officially referred to as COVID-19) which was found in late 2019 in Wuhan city, China. Till date, increased spread of novel coronavirus Disease (COVID-19) is even now at an uncontrollable rate and the amount of confirmed patients and mortality rate is still increasing at an exponential rate. Till 1st October 2020, from 216 different nations, regions, and territories, the World Health Organization (WHO) received reports of 33,842,282 confirmed cases and 1,010,635 confirmed deaths. This virus causes a variety of symptoms which can range from mild illness to moderate illness. Difficulty in breathing and death occur in severe cases. The common earliest manifestations include fever, cough, fatigue, myalgia, diarrhoea and headaches. The disease is mainly transmitted through respiratory droplets from a person who is infected, via coughing, sneezing or exhaling. Adding together expertizes across various domains to a variety of new and effective solutions are the need of hour. Very little is known about how corona virus affects the kidneys. There’s no such proof that shows if people with renal diseases are more susceptible than general public. Studies have been made over complications of coronavirus disease in patients with renal diseases and how to tackle them. This review article summarizes on the analysis of present situation with subject to coronavirus pandemic, its sequel on people with renal disorders and the seriousness of the disease. Majorly it gives an outline in management of this critical condition.